Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
1481 results found
2023 ∙ Ghaderi, S. Mohammadi, S. Heidari, M. Sharif Jalali, S. S. Mohammadi, M.
Post-COVID-19 Vaccination CNS Magnetic Resonance Imaging Findings: A Systematic Review
Adults Older adults COVID-19 Efficacy/effectiveness Safety
Rating:
Critically low
2023 ∙ Cromer, D. Steain, M. Reynaldi, A. Schlub, T. E. Khan, S. R. Sasson, S. C. Kent, S. J. Khoury, D. S. Davenport, M. P.
Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis
All age groups COVID-19 Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Liu, Y. Kuang, K.
Predictors of COVID-19 vaccination hesitancy in China: a meta-analysis
Western Pacific China All age groups COVID-19 Acceptance
Rating:
Not applicable
2023 ∙ Kigongo, E. Kabunga, A. Tumwesigye, R. Musinguzi, M. Izaruku, R. Acup, W.
Prevalence and predictors of COVID-19 vaccination hesitancy among healthcare workers in Sub-Saharan Africa: A systematic review and meta-analysis
Africa Healthcare workers COVID-19 Acceptance
Rating:
Not applicable
2023 ∙ Clerici, Bianca Scavone, Mariangela Birocchi, Simone Aloise, Chiara Peroni, Benedetta Negrini, Alessandra Ghali, Claudia Casazza, Giovanni Podda, Gian Marco
Prevalence of anti-platelet factor 4 antibodies in healthy vaccinees with adenoviral vector vaccines-A systematic review and meta-analysis
All age groups COVID-19 Safety
Rating:
Critically low
2023 ∙ Alimoradi, Z. Sallam, M. Jafari, E. Potenza, M. N. Pakpour, A. H.
Prevalence of COVID-19 vaccine acceptance among migrant and refugee groups: A systematic review and meta-analysis
Adults Older adults COVID-19 Acceptance
Rating:
Not applicable
2023 ∙ McKinley, C. J. Limbu, Y.
Promoter or barrier? Assessing how social media predicts Covid-19 vaccine acceptance and hesitancy: A systematic review of primary series and booster vaccine investigations
All age groups COVID-19 Acceptance
Rating:
Not applicable
2023 ∙ Rahman, M. O. Kamigaki, T. Thandar, M. M. Haruyama, R. Yan, F. Shibamura-Fujiogi, M. Khin Maung Soe, J. Islam, M. R. Yoneoka, D. Miyahara, R. Ota, E. Suzuki, M.
Protection of the third-dose and fourth-dose mRNA vaccines against SARS-CoV-2 Omicron subvariant: a systematic review and meta-analysis
All age groups COVID-19 Efficacy/effectiveness
Rating:
Low
2023 ∙ Watanabe, A. Iwagami, M. Yasuhara, J. Takagi, H. Kuno, T.
Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis
All age groups COVID-19 Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Bobrovitz, N. Ware, H. Ma, X. Li, Z. Hosseini, R. Cao, C. Selemon, A. Whelan, M. Premji, Z. Issa, H. Cheng, B. Abu Raddad, L. J. Buckeridge, D. L. Van Kerkhove, M. D. Piechotta, V. Higdon, M. M. Wilder-Smith, A. Bergeri, I. Feikin, D. R. Arora, R. K. Patel, M. K. Subissi, L.
Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression
All age groups COVID-19 Efficacy/effectiveness Administration
Rating:
Critically low
Loading...